- Pharmaceutical companies
- Lundbeck
Lundbeck
Phone: 4536301311
Fax: 4536301940
| Type | Aktieselskab |
|---|---|
| Traded as | Nasdaq Copenhagen: HLUN A Nasdaq Copenhagen: HLUN B |
| Industry | Pharmaceuticals |
| Founded | 1915 (1915) |
| Founder | Hans Lundbeck |
| Headquarters | Copenhagen, Denmark |
| Key people | Deborah Dunsire (CEO) Joerg Hornstein (CFO) |
| Website | www.lundbeck.com |
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases. For this purpose, Lundbeck is engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at the disease areas within psychiatry and neurology.
For detailed contact information visit location pages below.
Lundbeck's locations around the world
Europe
Clinical Trials sponsored by Lundbeck
-
Lundbeck FoundationCompletedPostoperative Pain | Analgesic EfficacyDenmark
-
Lundbeck LLCCompletedInfantile Spasms | Refractory Complex Partial Seizures in Adults
-
Lundbeck LLCCompletedAdult Refractory Complex Partial SeizuresUnited States
-
Lundbeck LLCCompletedLennox-Gastaut Syndrome
-
Lundbeck FoundationCompletedPostoperative Urinary RetentionDenmark
-
Lundbeck LLCWithdrawn
-
Lundbeck LLCCompletedEpilepsy | Epilepsy, Generalized | SeizuresUnited States, Belarus, India, Australia, Lithuania
-
Lundbeck LLCCompletedEpilepsy | Epilepsy, Generalized | SeizuresUnited States
-
Lundbeck LLCCompletedPsychotic Disorders | Parkinson's DiseaseUnited States, India, Italy
-
Lundbeck LLCCompleted